Tesamorelin
Research Compound
$98
| Pack size | 1 vial, size selected above |
| Compound type | Synthetic GHRH (1-44) analog |
| Sequence | trans-3-hexenoyl-hGHRH(1-44)-NH2 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.9 g/mol |
| CAS number | 218949-48-5 |
| Form | Lyophilized powder |
| Purity | 99% Pure |
| Storage | Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol. |
| Intended use | Laboratory research only |
This product is sold exclusively for laboratory research use by qualified professionals and institutions. It is not a drug, food, cosmetic, or dietary supplement, and is not approved for use in humans or animals. Handling must be performed only by trained personnel in a controlled research setting.
Research overview
Tesamorelin is a synthetic peptide made of all 44 amino acids of human growth hormone-releasing hormone with a trans-3-hexenoic acid group added. It has been approved since 2010 as a prescription medicine for HIV-associated lipodystrophy and is used in research on GHRH signaling and visceral fat.
Research areas
- GHRH receptor signaling
- Visceral adiposity research
- Growth hormone axis
Sources
Handling and storage
Store lyophilized powder at -20°C. Once reconstituted, refrigerate at 2-8°C and use within the timeframe indicated by your lab protocol.